[IKT] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
12-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 0.02%
YoY- -76.02%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 0 116 7 1,363 220 167 -
PBT -4,960 -5,778 -4,640 -2,636 -422 -2,344 16.15%
Tax 0 37 -4,640 -2,628 -414 -2,339 -
NP -4,960 -5,778 -4,640 -2,636 -422 -2,344 16.15%
Tax Rate - - - - - - -
Total Cost 4,960 5,894 4,646 3,999 641 2,511 14.56%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin 0.00 -4,963.46 -70,817.14 -193.40 -192.12 -1,404.30 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -0.66 -1.11 -1.10 -1.29 -0.31 -1.72 -17.41%
EPS Diluted -0.66 -1.11 -1.10 -1.29 -0.31 -1.72 -17.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.